What is a key consideration when tapering off intravenous (IV) steroids after a suppressive dose in the management of non-life-threatening systemic lupus erythematosus (SLE)?

A) Rapid discontinuation to minimize side effects
B) Gradual tapering to prevent disease flare-ups
C) Switching to a higher dose for sustained suppression
D) Introducing oral steroids for a more controlled transition